ReproCELL, Inc.

12
Strong Sell
  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: JP3974770004
JPY
137.00
5 (3.79%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
ReproCELL, Inc. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
No of Months
12
12
12
12
12
12
Profit Before Tax
-587.00
45.00
-28.00
-303.00
-573.00
-811.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
142.00
-224.00
-96.00
-22.00
114.00
46.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
-383.00
6.00
-11.00
-140.00
-246.00
-648.00
Cash Flow from Investing Activities
57.00
-795.00
404.00
-1,087.00
-2,144.00
-1,416.00
Cash Flow from Financing Activities
0.00
680.00
544.00
482.00
2,384.00
4.00
Net Cash Inflow / Outflow
-219.00
-115.00
1,024.00
-722.00
35.00
-1,984.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
105.00
-6.00
87.00
22.00
41.00
77.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in JPY Million
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of ReproCELL, Inc.
Markets Mojo
Figures in Million
consolidated Cash Flow Results
Markets Mojo
Markets Mojo
Change(JPY)
Change(%)
Profit Before Tax
-587.388
1486.931
-2,073.00
-139.50%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
142.119
-1848.257
1,990.00
107.69%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
-383.526
2690.672
-3,073.00
-114.25%
Cash Flow from Investing Activities
57.94
-3840.349
3,897.00
101.51%
Cash Flow from Financing Activities
0
-1908.2
1,908.00
100.00%
Net Cash Inflow / Outflow
-219.664
-3034.011
2,815.00
92.76%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
105.922
23.866
82.00
343.82%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Mar'26
stock-summary

YoY Growth in year ended Mar 2026 is -6,200.30% vs 154.90% in Mar 2025

Mar'26
Mar'25
Change(%)
Cash Flow from Operating Activities
-383.53
6.29
-6,200.30%